- Home
- AEON vs SINT Comparison
AEON vs SINT Comparison
Compare AEON & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEON
- SINT
- Stock Information
- Founded
- AEON N/A
- SINT 1996
- Country
- AEON United States
- SINT United States
- Employees
- AEON N/A
- SINT N/A
- Industry
- AEON Biotechnology: Pharmaceutical Preparations
- SINT Medical/Dental Instruments
- Sector
- AEON Health Care
- SINT Health Care
- Exchange
- AEON Nasdaq
- SINT Nasdaq
- Market Cap
- AEON 8.0M
- SINT 7.9M
- IPO Year
- AEON N/A
- SINT 2014
- Fundamental
- Price
- AEON $0.64
- SINT $2.87
- Analyst Decision
- AEON Strong Buy
- SINT Strong Buy
- Analyst Count
- AEON 1
- SINT 1
- Target Price
- AEON $360.00
- SINT $28.00
- AVG Volume (30 Days)
- AEON 104.9K
- SINT 246.9K
- Earning Date
- AEON 08-19-2025
- SINT 08-19-2025
- Dividend Yield
- AEON N/A
- SINT N/A
- EPS Growth
- AEON N/A
- SINT N/A
- EPS
- AEON 117.22
- SINT N/A
- Revenue
- AEON N/A
- SINT $2,569,000.00
- Revenue This Year
- AEON N/A
- SINT N/A
- Revenue Next Year
- AEON N/A
- SINT $87.50
- P/E Ratio
- AEON $0.01
- SINT N/A
- Revenue Growth
- AEON N/A
- SINT N/A
- 52 Week Low
- AEON $0.38
- SINT $1.71
- 52 Week High
- AEON $115.57
- SINT $8.60
- Technical
- Relative Strength Index (RSI)
- AEON 32.28
- SINT 50.97
- Support Level
- AEON $0.70
- SINT $2.61
- Resistance Level
- AEON $0.75
- SINT $2.96
- Average True Range (ATR)
- AEON 0.05
- SINT 0.15
- MACD
- AEON -0.01
- SINT 0.04
- Stochastic Oscillator
- AEON 1.33
- SINT 80.02
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.
About SINT SiNtx Technologies Inc.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.